1. Home
  2. PTGX vs TSLX Comparison

PTGX vs TSLX Comparison

Compare PTGX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$136.76

Market Cap

9.3B

Sector

Health Care

ML Signal

HOLD

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$18.23

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTGX
TSLX
Founded
2006
2010
Country
United States
United States
Employees
141
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
9.3B
1.8B
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
PTGX
TSLX
Price
$136.76
$18.23
Analyst Decision
Strong Buy
Buy
Analyst Count
13
9
Target Price
★ $108.23
$21.61
AVG Volume (30 Days)
★ 526.9K
379.8K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
★ 10.82%
EPS Growth
N/A
★ N/A
EPS
★ 2.35
0.15
Revenue
N/A
N/A
Revenue This Year
$874.25
N/A
Revenue Next Year
N/A
$1.20
P/E Ratio
★ $58.44
$121.00
Revenue Growth
N/A
N/A
52 Week Low
$62.24
$16.04
52 Week High
$160.81
$23.19

Technical Indicators

Market Signals
Indicator
PTGX
TSLX
Relative Strength Index (RSI) 40.35 52.24
Support Level $130.63 $17.20
Resistance Level $142.20 $18.59
Average True Range (ATR) 4.74 0.32
MACD -0.99 0.01
Stochastic Oscillator 12.72 75.00

Price Performance

Historical Comparison
PTGX
TSLX

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: